查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1712742

2025年藥品無菌測試全球市場報告

Pharmaceutical Sterility Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年藥品無菌測試的市場規模將快速成長。到 2029 年，這一數字將成長至 31.8 億美元，年複合成長率（CAGR）為 20.0%。預測期內的成長可歸因於生物製藥、個人化醫療的成長、外包趨勢的增加、對品質保證的重視以及大流行防範措施。預測期內的關鍵趨勢包括快速微生物學方法、配方產品、資料完整性和數位化、自動化和機器人技術以及先進的分析技術。

藥品無菌測試市場的發展歸因於藥品上市的快速增加和研發（R&D）投資的增加。在藥品生產過程中保持無菌狀態對於防止污染和確保藥品中不存在活微生物至關重要。值得注意的是，2022年3月，英國政府承諾撥款3.47億美元（2.6億英鎊）支持創新治療方法和工具的研發舉措，顯示其對發展製藥業的承諾。此外，IQVIA 於 2021 年 12 月發布的一份報告預測，未來五年新藥上市數量將大幅增加，新產品支出也將大幅增加，尤其是在特種藥物、利基藥物和孤兒藥方面。

生技藥品銷售額的成長預計將顯著推動藥品無菌測試市場的成長。生物製劑生物來源的生技藥品，包括疫苗、血液和血液成分、過敏原、體細胞、基因療法藥物、組織和重組治療性蛋白質等多種產品。確保這些生技藥品的無菌性至關重要，而藥品無菌測試提供了必要的品管，以確保這些產品在給患者服用之前沒有受到微生物污染。例如，2023 年 11 月，加拿大監管機構專利和藥品價格審查委員會報告稱，抗癌藥物的銷售額在 2021 年成長了 10%，2022 年進一步成長了 12%。這些生技藥品銷售趨勢凸顯了對無菌測試服務日益成長的需求，以確保這些救命療法的安全性和有效性。因此，生技藥品銷售的激增是藥品無菌測試市場的主要驅動力，凸顯了嚴格的測試通訊協定在生物製藥產業中的關鍵作用。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、感染疾病、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球藥品無菌測試市場的 PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素、限制因素）
  • 最終用途產業分析
  • 全球藥品無菌測試市場：成長率分析
  • 全球藥品無菌測試市場表現：規模與成長，2019-2024
  • 全球藥品無菌測試市場預測：規模與成長，2024-2029，2034
  • 全球藥品無菌測試總目標市場（TAM）

第6章市場區隔

  • 全球藥品無菌測試市場樣本、績效及預測（2019-2024、2024-2029、2034）
  • 無菌藥品
  • 醫療設備
  • 生技藥品和治療學
  • 全球藥品無菌測試市場（按產品類型、性能和預測）2019-2024 年、2024-2029 年、2034 年
  • 裝置
  • 套件和試劑
  • 服務
  • 全球藥品無菌測試市場類型、表現及預測（2019-2024、2024-2029、2034）
  • 內部
  • 外包
  • 全球藥品無菌測試市場（按測試類型、性能和預測）2019-2024 年、2024-2029 年、2034 年
  • 無菌測試
  • 微生物附著量測試
  • 細菌內毒素檢測
  • 全球藥品無菌測試市場（依最終用戶、績效及預測）2019-2024、2024-2029、2034
  • 配藥藥房
  • 醫療設備公司
  • 製藥公司
  • 全球藥品無菌測試市場：無菌藥物細分（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 注射藥物
  • 點滴解決方案
  • 眼藥水
  • 全球藥品無菌測試市場：醫療設備細分（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 手術器械
  • 植入
  • 導管
  • 全球藥品無菌測試市場：生技藥品及治療細分市場（按類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 疫苗
  • 基因治療
  • 細胞療法

第7章 區域和國家分析

  • 全球藥品無菌測試市場各地區、績效及預測（2019-2024、2024-2029、2034）
  • 全球藥品無菌測試市場（依國家、地區、績效及預測）2019-2024、2024-2029、2034

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 藥品無菌測試市場：競爭格局
  • 藥品無菌測試市場：公司簡介
    • Pacific Biolabs Inc. Overview, Products and Services, Strategy and Financial Analysis
    • STERIS Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Boston Analytical Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Gibraltar Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Sartorius AG Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Solvias AG
  • SGS SA
  • Toxikon Inc.
  • Pace Analytical Services LLC
  • Charles River Laboratories International Inc.
  • Nelson Laboratories Inc.
  • Rapid Micro Biosystems Inc.
  • bioMerieux Inc.
  • Merck KGaA
  • WuXi AppTec
  • Sotera Health LLC
  • Dynalabs LLC
  • Infinity Laboratories
  • Eurofins Scientific SE
  • Avomeen Analytical Services

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年藥品無菌測試市場：提供新機會的國家
  • 2029年藥品無菌測試市場：細分領域帶來新機會
  • 2029年藥品無菌測試市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r32953

Pharmaceutical sterility testing is a critical process designed to determine whether biological parenteral products intended for human use contain any extraneous, viable microorganisms. Ensuring the absence of contaminants is crucial for patient safety and the overall quality of medical products. Sterility testing guarantees that the products offered are appropriately free from harmful microorganisms.

Within pharmaceutical sterility testing, two primary types exist: in-house testing and outsourced testing. Various tests, including sterility testing, bioburden testing, and bacterial endotoxin testing, are conducted on sterile drugs, medical devices, biologics, and therapeutics. The bacterial endotoxin test, an in vitro assay, detects bacterial endotoxins by lysing blood cells from horseshoe crabs. Products utilized in this process include instruments, kits, reagents, and services.

The pharmaceutical sterility testing market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical sterility testing market statistics, including pharmaceutical sterility testing industry global market size, regional shares, competitors with a pharmaceutical sterility testing market share, detailed pharmaceutical sterility testing market segments, pharmaceutical sterility testing market trends and opportunities, and any further data you may need to thrive in the pharmaceutical sterility testing industry. This pharmaceutical sterility testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmaceutical sterility testing market size has grown strongly in recent years. It will grow from $1.41 billion in 2024 to $1.54 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to rising demand for quality pharmaceutical products, growing emphasis on drug safety and efficacy, growing demand for biologics and biosimilar drugs, increasing prevalence of infectious diseases, and rising investments in life science research.

The pharmaceutical sterility testing market size is expected to see rapid growth in the next few years. It will grow to $3.18 billion in 2029 at a compound annual growth rate (CAGR) of 20.0%. The growth in the forecast period can be attributed to biopharmaceutical growth, personalized medicine, growing trend of outsourcing, quality assurance emphasis, pandemic preparedness. Major trends in the forecast period include rapid microbiological methods, combination products, data integrity and digitalization, automation and robotics, advanced analytical techniques.

Growth in the pharmaceutical sterility testing market is attributed to an upsurge in drug launches and increased investment in research and development (R&D). Maintaining sterility in drug manufacturing is crucial to prevent contamination and ensure the absence of viable microorganisms in medications. Notably, in March 2022, the UK government pledged a substantial $347 million (£260 million) towards R&D initiatives for innovative treatments and tools, signifying a commitment to advancing the pharmaceutical landscape. Additionally, IQVIA's report from December 2021 projects a significant rise in new drug introductions over the next five years, particularly in specialty, niche, and orphan drugs, accompanied by a substantial increase in spending on new products.

The rise in biologics sales is anticipated to significantly propel the growth of the pharmaceutical sterility testing market. Biologics, which are medicines derived from living organisms, encompass a wide range of products, including vaccines, blood and blood components, allergenics, somatic cells, gene therapies, tissues, and recombinant therapeutic proteins. Ensuring the sterility of these biologics is critical, as pharmaceutical sterility testing provides essential quality control to verify that these products are free from microbial contamination prior to patient administration. For example, in November 2023, the Patented Medicine Prices Review Board, a Canada-based regulatory agency, reported that sales of oncology medicines increased by 10% in 2021 and saw a more significant rise of 12% in 2022. This growing trend in biologics sales underscores the heightened demand for sterility testing services to maintain the safety and efficacy of these life-saving treatments. Consequently, the surge in biologics sales is a key driver for the pharmaceutical sterility testing market, highlighting the critical role of rigorous testing protocols in the biopharmaceutical industry.

Key players in the pharmaceutical sterility testing market are introducing technologically advanced solutions, such as the sterility test isolator workstation (STIW), to address testing challenges and minimize erroneous results. The STIW, a specialized containment system, creates a sterile environment for conducting sterility tests on pharmaceutical products. For example, AUSTAR Group unveiled the Sterility Test Isolator Workstation (STIW) in March 2022 as part of their 'Standards' product range, featuring UDAF and TURB models. This barrier isolator technology significantly reduces false positives, fostering confidence in lab results while lowering operational costs. Designed for secure sterility testing, the STIW ensures protection against contamination, adhering to stringent guidelines. Its integrated bio-decontamination system expedites processing within 30 minutes, optimizing workflow efficiency for operators.

Major companies operating in the pharmaceutical sterility testing market include Pacific Biolabs Inc., STERIS Corporation, Boston Analytical Inc., Gibraltar Laboratories Inc., Sartorius AG, Solvias AG, SGS S.A., Toxikon Inc., Pace Analytical Services LLC, Charles River Laboratories International Inc., Nelson Laboratories Inc., Rapid Micro Biosystems Inc., bioMerieux Inc., Merck KGaA, WuXi AppTec, Sotera Health LLC, Dynalabs LLC, Infinity Laboratories, Eurofins Scientific SE, Avomeen Analytical Services, Microbac Laboratories Inc., Analytical Lab Group LLC, North American Science Associates Inc., Medical Device Testing Services Inc., Microtest Laboratories Inc., BioScreen Testing Services Inc., Microchem Laboratory Inc., Bactolac Pharmaceutical Inc., Micro Quality Labs Inc., Boston Microfluidics Inc., BioPharma Services Inc., Microbiology Research Associates, BioScience Laboratories Inc.

North America was the largest region in the pharmaceutical sterility testing market in 2024. The Middle East is expected to be the fastest-growing region in the global pharmaceutical sterility testing market share during the forecast period. The regions covered in the pharmaceutical sterility testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the pharmaceutical sterility testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The pharmaceutical sterility testing market includes revenues earned by entities by membrane filtration, direct transfer (product immersion), and product flush. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Sterility Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical sterility testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical sterility testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical sterility testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Sample: Sterile Drugs; Medical Devices; Biologics and Therapeutics
  • 2) By Product Type: Instruments; Kits and Reagents; Services
  • 3) By Type: In- house; Outsourcing
  • 4) By Test Type: Sterility Testing; Bioburden Testing; Bacterial Endotoxin Testing
  • 5) By End- User: Compounding Pharmacies; Medical Devices Companies; Pharmaceutical Companies
  • Subsegments:
  • 1) By Sterile Drugs: Injectable Drugs; Infusion Solutions; Ophthalmic Solutions
  • 2) By Medical Devices: Surgical Instruments; Implants; Catheters
  • 3) By Biologics And Therapeutics: Vaccines; Gene Therapies; Cell Therapies
  • Companies Mentioned: Pacific Biolabs Inc.; STERIS Corporation; Boston Analytical Inc.; Gibraltar Laboratories Inc.; Sartorius AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical Sterility Testing Market Characteristics

3. Pharmaceutical Sterility Testing Market Trends And Strategies

4. Pharmaceutical Sterility Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Pharmaceutical Sterility Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Pharmaceutical Sterility Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Pharmaceutical Sterility Testing Market Growth Rate Analysis
  • 5.4. Global Pharmaceutical Sterility Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Pharmaceutical Sterility Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Pharmaceutical Sterility Testing Total Addressable Market (TAM)

6. Pharmaceutical Sterility Testing Market Segmentation

  • 6.1. Global Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sterile Drugs
  • Medical Devices
  • Biologics and Therapeutics
  • 6.2. Global Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Kits and Reagents
  • Services
  • 6.3. Global Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • In-house
  • Outsourcing
  • 6.4. Global Pharmaceutical Sterility Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sterility Testing
  • Bioburden Testing
  • Bacterial Endotoxin Testing
  • 6.5. Global Pharmaceutical Sterility Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Compounding Pharmacies
  • Medical Devices Companies
  • Pharmaceutical Companies
  • 6.6. Global Pharmaceutical Sterility Testing Market, Sub-Segmentation Of Sterile Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Injectable Drugs
  • Infusion Solutions
  • Ophthalmic Solutions
  • 6.7. Global Pharmaceutical Sterility Testing Market, Sub-Segmentation Of Medical Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Surgical Instruments
  • Implants
  • Catheters
  • 6.8. Global Pharmaceutical Sterility Testing Market, Sub-Segmentation Of Biologics And Therapeutics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Vaccines
  • Gene Therapies
  • Cell Therapies

7. Pharmaceutical Sterility Testing Market Regional And Country Analysis

  • 7.1. Global Pharmaceutical Sterility Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Pharmaceutical Sterility Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmaceutical Sterility Testing Market

  • 8.1. Asia-Pacific Pharmaceutical Sterility Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmaceutical Sterility Testing Market

  • 9.1. China Pharmaceutical Sterility Testing Market Overview
  • 9.2. China Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmaceutical Sterility Testing Market

  • 10.1. India Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmaceutical Sterility Testing Market

  • 11.1. Japan Pharmaceutical Sterility Testing Market Overview
  • 11.2. Japan Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmaceutical Sterility Testing Market

  • 12.1. Australia Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmaceutical Sterility Testing Market

  • 13.1. Indonesia Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmaceutical Sterility Testing Market

  • 14.1. South Korea Pharmaceutical Sterility Testing Market Overview
  • 14.2. South Korea Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharmaceutical Sterility Testing Market

  • 15.1. Western Europe Pharmaceutical Sterility Testing Market Overview
  • 15.2. Western Europe Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharmaceutical Sterility Testing Market

  • 16.1. UK Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharmaceutical Sterility Testing Market

  • 17.1. Germany Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharmaceutical Sterility Testing Market

  • 18.1. France Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharmaceutical Sterility Testing Market

  • 19.1. Italy Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharmaceutical Sterility Testing Market

  • 20.1. Spain Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharmaceutical Sterility Testing Market

  • 21.1. Eastern Europe Pharmaceutical Sterility Testing Market Overview
  • 21.2. Eastern Europe Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharmaceutical Sterility Testing Market

  • 22.1. Russia Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharmaceutical Sterility Testing Market

  • 23.1. North America Pharmaceutical Sterility Testing Market Overview
  • 23.2. North America Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharmaceutical Sterility Testing Market

  • 24.1. USA Pharmaceutical Sterility Testing Market Overview
  • 24.2. USA Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharmaceutical Sterility Testing Market

  • 25.1. Canada Pharmaceutical Sterility Testing Market Overview
  • 25.2. Canada Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharmaceutical Sterility Testing Market

  • 26.1. South America Pharmaceutical Sterility Testing Market Overview
  • 26.2. South America Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharmaceutical Sterility Testing Market

  • 27.1. Brazil Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharmaceutical Sterility Testing Market

  • 28.1. Middle East Pharmaceutical Sterility Testing Market Overview
  • 28.2. Middle East Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharmaceutical Sterility Testing Market

  • 29.1. Africa Pharmaceutical Sterility Testing Market Overview
  • 29.2. Africa Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharmaceutical Sterility Testing Market Competitive Landscape And Company Profiles

  • 30.1. Pharmaceutical Sterility Testing Market Competitive Landscape
  • 30.2. Pharmaceutical Sterility Testing Market Company Profiles
    • 30.2.1. Pacific Biolabs Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. STERIS Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Boston Analytical Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Gibraltar Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Sartorius AG Overview, Products and Services, Strategy and Financial Analysis

31. Pharmaceutical Sterility Testing Market Other Major And Innovative Companies

  • 31.1. Solvias AG
  • 31.2. SGS S.A.
  • 31.3. Toxikon Inc.
  • 31.4. Pace Analytical Services LLC
  • 31.5. Charles River Laboratories International Inc.
  • 31.6. Nelson Laboratories Inc.
  • 31.7. Rapid Micro Biosystems Inc.
  • 31.8. bioMerieux Inc.
  • 31.9. Merck KGaA
  • 31.10. WuXi AppTec
  • 31.11. Sotera Health LLC
  • 31.12. Dynalabs LLC
  • 31.13. Infinity Laboratories
  • 31.14. Eurofins Scientific SE
  • 31.15. Avomeen Analytical Services

32. Global Pharmaceutical Sterility Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmaceutical Sterility Testing Market

34. Recent Developments In The Pharmaceutical Sterility Testing Market

35. Pharmaceutical Sterility Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Pharmaceutical Sterility Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Pharmaceutical Sterility Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Pharmaceutical Sterility Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer